CEL-SCI Receives $225,000 NIH Research Grant to Develop Rheumatoid Arthritis Treatment

Pre-clinical studies show CEL-SCIā€™s LEAPS technology prevented the development and lessened the severity of rheumatoid arthritis July 15, 2014 CEL-SCI CorporationĀ announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant in the amount of $225,000 from the National Institute of Arthritis Muscoskeletal and Skin Diseases (NIAMS), which is part of the National Institutes of …